Other OTC • Healthcare • Biotechnology • USD
Clarus Therapeutics Holdings, Inc. (CRXWQ) and trades at $0.00. The 52-week range is 3.0E-4-3.0E-4.
Key metrics include annual revenue of $13.96M.
The stock has a beta of 0.00, operates in the Healthcare sector.
Be the first to know when stocks drop below their intrinsic value.
